Further we provide the first functional evidence that re-activation of Testisin gene expression, through exogenous expression of Testisin cDNA, suppresses in vivo testicular tumour growth and colony forming ability in vitro, supporting the hypothesis that Testisin inactivation confers a selectable advantage for testicular tumours. This evidence concerns the gene PRSS21 and neoplasm of testis.